125 related articles for article (PubMed ID: 17095587)
1. Pharmacological characterization of a novel nonpeptide antagonist of the human gonadotropin-releasing hormone receptor, NBI-42902.
Struthers RS; Xie Q; Sullivan SK; Reinhart GJ; Kohout TA; Zhu YF; Chen C; Liu XJ; Ling N; Yang W; Maki RA; Bonneville AK; Chen TK; Bozigian HP
Endocrinology; 2007 Feb; 148(2):857-67. PubMed ID: 17095587
[TBL] [Abstract][Full Text] [Related]
2. Effect of SKI2670, a novel, orally active, non-peptide GnRH antagonist, on hypothalamic-pituitary-gonadal axis.
Kim SM; Yoo T; Lee SY; Kim EJ; Lee SM; Lee MH; Han MY; Jung SH; Choi JH; Ryu KH; Kim HT
Life Sci; 2015 Oct; 139():166-74. PubMed ID: 26321528
[TBL] [Abstract][Full Text] [Related]
3. Allosteric and orthosteric binding modes of two nonpeptide human gonadotropin-releasing hormone receptor antagonists.
Sullivan SK; Brown MS; Gao Y; Loweth CJ; Lio FM; Crowe PD; Struthers RS; Betz SF
Biochemistry; 2006 Dec; 45(51):15327-37. PubMed ID: 17176055
[TBL] [Abstract][Full Text] [Related]
4. Suppression of serum luteinizing hormone in postmenopausal women by an orally administered nonpeptide antagonist of the gonadotropin-releasing hormone receptor (NBI-42902).
Struthers RS; Chen T; Campbell B; Jimenez R; Pan H; Yen SS; Bozigian HP
J Clin Endocrinol Metab; 2006 Oct; 91(10):3903-7. PubMed ID: 16849403
[TBL] [Abstract][Full Text] [Related]
5. Biological characterization of a novel, orally active small molecule gonadotropin-releasing hormone (GnRH) antagonist using castrated and intact rats.
Anderes KL; Luthin DR; Castillo R; Kraynov EA; Castro M; Nared-Hood K; Gregory ML; Pathak VP; Christie LC; Paderes G; Vazir H; Ye Q; Anderson MB; May JM
J Pharmacol Exp Ther; 2003 May; 305(2):688-95. PubMed ID: 12606616
[TBL] [Abstract][Full Text] [Related]
6. 3-[(2R)-Amino-2-phenylethyl]-1-(2,6-difluorobenzyl)-5-(2-fluoro-3-methoxyphenyl)- 6-methylpyrimidin-2,4-dione (NBI 42902) as a potent and orally active antagonist of the human gonadotropin-releasing hormone receptor. Design, synthesis, and in vitro and in vivo characterization.
Tucci FC; Zhu YF; Struthers RS; Guo Z; Gross TD; Rowbottom MW; Acevedo O; Gao Y; Saunders J; Xie Q; Reinhart GJ; Liu XJ; Ling N; Bonneville AK; Chen T; Bozigian H; Chen C
J Med Chem; 2005 Feb; 48(4):1169-78. PubMed ID: 15715483
[TBL] [Abstract][Full Text] [Related]
7. Kinetics of nonpeptide antagonist binding to the human gonadotropin-releasing hormone receptor: Implications for structure-activity relationships and insurmountable antagonism.
Sullivan SK; Hoare SR; Fleck BA; Zhu YF; Heise CE; Struthers RS; Crowe PD
Biochem Pharmacol; 2006 Sep; 72(7):838-49. PubMed ID: 16930559
[TBL] [Abstract][Full Text] [Related]
8. Suppression of the hypothalamic-pituitary-gonadal axis by TAK-385 (relugolix), a novel, investigational, orally active, small molecule gonadotropin-releasing hormone (GnRH) antagonist: studies in human GnRH receptor knock-in mice.
Nakata D; Masaki T; Tanaka A; Yoshimatsu M; Akinaga Y; Asada M; Sasada R; Takeyama M; Miwa K; Watanabe T; Kusaka M
Eur J Pharmacol; 2014 Jan; 723():167-74. PubMed ID: 24333551
[TBL] [Abstract][Full Text] [Related]
9. Stimulation of luteinizing hormone release by sodium fluoride is independent of protein kinase-C activity and unaffected by desensitization to gonadotropin-releasing hormone.
Waters SB; Hawes BE; Conn PM
Endocrinology; 1990 May; 126(5):2583-91. PubMed ID: 2158431
[TBL] [Abstract][Full Text] [Related]
10. The relationship between gonadotropin-releasing hormone-stimulated luteinizing hormone release and inositol phosphate production: studies with calcium antagonists and protein kinase C activators.
Huckle WR; Conn PM
Endocrinology; 1987 Jan; 120(1):160-9. PubMed ID: 3023025
[TBL] [Abstract][Full Text] [Related]
11. Overlapping, nonidentical binding sites of different classes of nonpeptide antagonists for the human gonadotropin-releasing hormone receptor.
Betz SF; Reinhart GJ; Lio FM; Chen C; Struthers RS
J Med Chem; 2006 Jan; 49(2):637-47. PubMed ID: 16420049
[TBL] [Abstract][Full Text] [Related]
12. Discovery of a thieno[2,3-d]pyrimidine-2,4-dione bearing a p-methoxyureidophenyl moiety at the 6-position: a highly potent and orally bioavailable non-peptide antagonist for the human luteinizing hormone-releasing hormone receptor.
Sasaki S; Cho N; Nara Y; Harada M; Endo S; Suzuki N; Furuya S; Fujino M
J Med Chem; 2003 Jan; 46(1):113-24. PubMed ID: 12502365
[TBL] [Abstract][Full Text] [Related]
13. Development of gonadotrope desensitization to gonadotropin-releasing hormone (GnRH) and recovery are not coupled to inositol phosphate production or GnRH receptor number.
Hawes BE; Conn PM
Endocrinology; 1992 Dec; 131(6):2681-9. PubMed ID: 1332845
[TBL] [Abstract][Full Text] [Related]
14. Suppression of a pituitary-ovarian axis by chronic oral administration of a novel nonpeptide gonadotropin-releasing hormone antagonist, TAK-013, in cynomolgus monkeys.
Hara T; Araki H; Kusaka M; Harada M; Cho N; Suzuki N; Furuya S; Fujino M
J Clin Endocrinol Metab; 2003 Apr; 88(4):1697-704. PubMed ID: 12679460
[TBL] [Abstract][Full Text] [Related]
15. Pharmacological profile of a new, potent, and long-acting gonadotropin-releasing hormone antagonist: degarelix.
Broqua P; Riviere PJ; Conn PM; Rivier JE; Aubert ML; Junien JL
J Pharmacol Exp Ther; 2002 Apr; 301(1):95-102. PubMed ID: 11907162
[TBL] [Abstract][Full Text] [Related]
16. Pharmacological characterization of linzagolix, a novel, orally active, non-peptide antagonist of gonadotropin-releasing hormone receptors.
Tezuka M; Tamai Y; Kuramochi Y; Kobayashi K; Fushimi N; Kiguchi S
Clin Exp Pharmacol Physiol; 2022 Oct; 49(10):1082-1093. PubMed ID: 35690889
[TBL] [Abstract][Full Text] [Related]
17. Species selectivity of nonpeptide antagonists of the gonadotropin-releasing hormone receptor is determined by residues in extracellular loops II and III and the amino terminus.
Reinhart GJ; Xie Q; Liu XJ; Zhu YF; Fan J; Chen C; Struthers RS
J Biol Chem; 2004 Aug; 279(33):34115-22. PubMed ID: 15155770
[TBL] [Abstract][Full Text] [Related]
18. 2-phenyl-4-piperazinylbenzimidazoles: orally active inhibitors of the gonadotropin releasing hormone (GnRH) receptor.
Pelletier JC; Chengalvala M; Cottom J; Feingold I; Garrick L; Green D; Hauze D; Huselton C; Jetter J; Kao W; Kopf GS; Lundquist JT; Mann C; Mehlmann J; Rogers J; Shanno L; Wrobel J
Bioorg Med Chem; 2008 Jul; 16(13):6617-40. PubMed ID: 18511284
[TBL] [Abstract][Full Text] [Related]
19. GnRH Antagonists Produce Differential Modulation of the Signaling Pathways Mediated by GnRH Receptors.
Sperduti S; Limoncella S; Lazzaretti C; Paradiso E; Riccetti L; Turchi S; Ferrigno I; Bertacchini J; Palumbo C; Potì F; Longobardi S; Millar RP; Simoni M; Newton CL; Casarini L
Int J Mol Sci; 2019 Nov; 20(22):. PubMed ID: 31703269
[TBL] [Abstract][Full Text] [Related]
20. Discovery of a novel, orally active, small molecule gonadotropin-releasing hormone (GnRH) receptor antagonist.
Li H; Anderes KL; Kraynov EA; Luthin DR; Do QQ; Hong Y; Tompkins E; Sun ET; Rajapakse R; Pathak VP; Christie LC; Feng J; Vazir H; Castillo R; Gregory ML; Castro M; Nared-Hood K; Paderes G; Anderson MB
J Med Chem; 2006 Jun; 49(11):3362-7. PubMed ID: 16722655
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
